NXL Projected Dividend Yield

Nexalin Technology Inc ( NASDAQ : NXL )

Nexalin Technology is a medical device company that designs and develops neurostimulation products to help combat the ongoing global mental health epidemic. Co. has developed a medical device, referred to as Generation 1, that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Co. has designed and developed new waveform technology to be emitted at 15 milliamps - referred to as Generation 2 which can penetrate deeper into the brain and stimulate associated structures of mental illness. Generation 2 is being tested in pilot trials, for anxiety, insomnia, and depression in the United States.

20 YEAR PERFORMANCE RESULTS